ProBio FAQ page banner - Find answers to common questions about antibodies, CGTs and mRNA CDMO services

Cross-Border BioVentures Summit

Breakthrough innovation can emerge anywhere, but realizing its full potential requires the right capital, partners, development strategy, and execution. The Cross-Border BioVentures Summit (CBBS) brings together investors, pharmaceutical business development leaders, biotechnology founders, and industry experts to explore how innovation is sourced, funded, developed, and commercialized across global ecosystems

Through practical discussions, case studies, company showcases, and networking opportunities, attendees will gain actionable insight into innovation sourcing, value creation, strategic partnerships, and global development strategies.

Who Will Be There

Healthcare Investors and VCs Pharma BD and Search & Evaluation Teams
Early-Stage and Growth-stage Biotechs
Cross-border ecosystem players and strategic partners

PLENARY KEYNOTE: Commercial Potential as the North Star

Presenter：Mike Myers, PhD Founder & President, ID4 Consulting Former Associate
VP, Lilly Labs Due Diligence

Drawing on decades of experience evaluating opportunities at Eli Lilly and across the biopharma industry, Mike Myers will examine the
factors that separate promising science from transformative products, and why clinical success alone is rarely enough to create lasting
value. Why do most scientifically successful therapies fail to become commercial successes?

Download Event Agenda

Explore Opportunities

Biotech Showcase Pitch applications

Biotech Showcase - Pitch Applications

Pitch to the Investors and Pharma Leaders Shaping Biotech’s Future

JPM is one of the most competitive environments in biotech. Companies often have only a few minutes to communicate their science, strategy, and value proposition before investors and pharma partners decide whether they want to spend more time.

This session will feature a live evaluation from a panel of investors, pharma BD leaders, and industry experts, giving founders direct insight into what drives attention, conviction, and follow-up interest.

Why Present?

Increase visibility among investors and pharma decision-makers.
Understand how external stakeholders evaluate opportunities and what drives conviction.
Refine positioning, messaging, and development narratives.
Learn what makes companies memorable in a highly competitive JPM environment.

Format

Curated group of presenting companies
10-minute, non-confidential presentations delivered to an investor panel
Live feedback from investors and pharma decision-makers
Audience Q&A and discussion

Lead Judges

Bob Draper

Associate VP, Customer Analytics & Insights, Eli Lilly

Leocadia Ruiz

VP of CMC, Raven Healthcare Incubator (RA Capital)

Application Process Application Deadline: November 23, 2026

Selection Notification: Early December

Apply to Present

Become a Sponsor

Sponsor the Cross-Border BioVentures Summit

Connect with the organizations shaping the future of biotech investment, development, and clinical advancement. The Cross-Border BioVentures Summit brings together healthcare investors, pharmaceutical business development leaders, biotechnology founders, and industry experts to explore how emerging innovations are funded, developed, and brought closer to clinical application across global markets.

The Summit offers sponsors an opportunity to engage with decision-makers navigating development strategy, clinical pathways, cross-border partnerships, and commercialization. For organizations supporting biotech companies through clinical development, investigator-initiated trials (IITs), regulatory strategy, and commercialization, the Summit provides a focused environment to build relationships with potential partners and clients.

Why Sponsor

Connect with decision-makers

Engage with biotech founders, healthcare investors, pharma BD leaders, and organizations evaluating development and partnering opportunities.

Build relevant business relationships

Develop connections with companies seeking clinical development expertise, regulatory support, manufacturing capabilities, and strategic partners.

Align your expertise with industry priorities

Participate in discussions around IITs, Decree 818, and accelerated development pathways in global drug development, and cross-border collaboration.

Demonstrate your capabilities

Position your organization as a knowledgeable partner helping biotech innovators navigate development challenges and advance their programs.

Increase visibility with a targeted audience

Build brand recognition through event programming, networking, and sponsorship benefits tailored to your organization's goals.

Become a Sponsor

Event Hosts

Alphabet Health Group (AHG) provides strategic advisory and business development support to biotechnology and life science organizations seeking to advance innovation and global growth opportunities.

ProBio is a biotechnology services company providing integrated drug development and manufacturing capabilities across biologics, cell therapies, and gene therapies.

Contact Us for More Event Details

Contact our team for custom technical documentation and consultations.